Stock Analysis

Three Compelling Dividend Stocks To Enhance Your Portfolio

Published

In the wake of a significant U.S. election outcome, global markets have experienced notable shifts, with U.S. stocks rallying to record highs amid expectations of growth-friendly policies and tax reforms. As investors navigate these dynamic conditions, dividend stocks emerge as a compelling option for those seeking stability and income potential in their portfolios amidst market volatility and evolving economic landscapes.

Top 10 Dividend Stocks

NameDividend YieldDividend Rating
Peoples Bancorp (NasdaqGS:PEBO)4.47%★★★★★★
Guaranty Trust Holding (NGSE:GTCO)6.90%★★★★★★
Globeride (TSE:7990)4.06%★★★★★★
GakkyushaLtd (TSE:9769)4.51%★★★★★★
China South Publishing & Media Group (SHSE:601098)4.35%★★★★★★
FALCO HOLDINGS (TSE:4671)6.67%★★★★★★
Kwong Lung Enterprise (TPEX:8916)6.32%★★★★★★
Citizens & Northern (NasdaqCM:CZNC)5.46%★★★★★★
Financial Institutions (NasdaqGS:FISI)4.32%★★★★★☆
Premier Financial (NasdaqGS:PFC)4.32%★★★★★☆

Click here to see the full list of 1936 stocks from our Top Dividend Stocks screener.

Let's review some notable picks from our screened stocks.

FinecoBank Banca Fineco (BIT:FBK)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: FinecoBank Banca Fineco S.p.A. offers a range of banking and investment products and services, with a market cap of approximately €9.07 billion.

Operations: FinecoBank Banca Fineco S.p.A. generates its revenue primarily from its banking segment, which amounts to €1.30 billion.

Dividend Yield: 4.5%

FinecoBank Banca Fineco reported a net income increase to €169.68 million for Q3 2024, up from €145.32 million the previous year, indicating solid earnings growth despite forecasts of a 1.2% annual decline over the next three years. The dividend yield is relatively low at 4.5%, and payments have been volatile over the past decade, though currently covered by earnings with a payout ratio of 67.9%.

BIT:FBK Dividend History as at Nov 2024

Luyan PharmaLtd (SZSE:002788)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Luyan Pharma Co., Ltd. is involved in the research, development, production, and sale of human health products in China with a market cap of CN¥3.48 billion.

Operations: Luyan Pharma Co., Ltd.'s revenue segments include the research, development, production, and sale of human health products in China.

Dividend Yield: 3.3%

Luyan Pharma Ltd. reported stable earnings for the nine months ending September 2024, with net income slightly decreasing to CNY 257.35 million from CNY 261.98 million a year prior. The company offers a dividend yield of 3.34%, placing it in the top quartile of CN market dividend payers, supported by a low cash payout ratio of 23.3%. Despite its short dividend history under ten years, payments have been reliable and well-covered by earnings and cash flow.

SZSE:002788 Dividend History as at Nov 2024

Sesoda (TWSE:1708)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Sesoda Corporation manufactures and markets sulfate of potash (SOP) in Taiwan with a market capitalization of NT$10.48 billion.

Operations: Sesoda Corporation's revenue is primarily derived from the production and sale of sulfate of potash (SOP).

Dividend Yield: 3.6%

Sesoda Corporation's dividend payments have been volatile over the past decade, though they are well-covered by earnings and cash flows, with a payout ratio of 42.8% and a cash payout ratio of 27.9%. Despite trading significantly below its estimated fair value, Sesoda has recently turned profitable, reporting substantial growth in net income for Q3 2024 at TWD 291.24 million compared to TWD 105.71 million last year, indicating potential stability in future dividends.

TWSE:1708 Dividend History as at Nov 2024

Seize The Opportunity

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com